Insulin

Global and China Insulin Market Research by Company, Type & Application 2013-2025

Report ID: HeyReport 33301 | Number of pages: 95 | Publish Date: Aug 2019 | Category: Lifesciences and Healthcare
Summary
Insulin (from the Latin, insula meaning island) is a peptide hormone produced by beta cells of the pancreatic islets. It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of, especially, glucose from the blood into fat, liver and skeletal muscle cells.In these tissues the absorbed glucose is converted into either glycogen via glycogenesis or fats (triglycerides) via lipogenesis, or, in the case of the liver, into both.Glucose production (and excretion into the blood) by the liver is strongly inhibited by high concentrations of insulin in the blood.Circulating insulin also affects the synthesis of proteins in a wide variety of tissues. It is therefore an anabolic hormone, promoting the conversion of small molecules in the blood into large molecules inside the cells. Low insulin levels in the blood have the opposite effect by promoting widespread catabolism. 
Market Segment as follows:
By Type
    Ultra-short-acting insulin
    Short-acting insulin
    In effect insulin
    Long-acting insulin
By Application
    Type 1 diabetes
    Type 2 diabetes
    Others diabetes
By Company
    Novartis
    Novo Nordisk
    Boehringer Ingelheim
    Bristol-Myers Squibb
    Eli Lilly
    MannKind
    Sanofi
    Merck
    Bioton
    GEA
    Emisphere
    Salix Pharmaceuticals
    Gan & Lee
    Dongbao
    United Laboratories (TUL)
    Takeda Pharmaceutical Company
    Shihuida PHARMA Group
    Henan Tian Fang Pharmaceutical
    Disha Pharmaceutical Group
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Interested in this report?
Get your sample now!
Table of Content
1 Market Overview
    1.1 Market Segment Overview
        1.1.1 Product Definition
        1.1.2 Market by Type
            1.1.2.1 Ultra-short-acting insulin
            1.1.2.2 Short-acting insulin
            1.1.2.3 In effect insulin
            1.1.2.4 Long-acting insulin
        1.1.3 Market by Application
            1.1.3.1 Type 1 diabetes
            1.1.3.2 Type 2 diabetes
            1.1.3.3 Others diabetes
    1.2 Global and China Market Size
        1.2.1 Global Overview
        1.2.2 China Overview
2 Global and China Market by Company
    2.1 Global
        2.1.1 Global Sales by Company
        2.1.2 Global Price by Company
    2.2 China
        2.2.1 China Sales by Company
        2.2.2 China Price by Company
3 Global and China Market by Type
    3.1 Global
        3.1.1 Global Sales by Type
        3.1.2 Global Price by Type
    3.2 China
        3.2.1 China Sales by Type
        3.2.2 China Price by Type
4 Global and China Market by Application
    4.1 Global
        4.1.1 Global Sales by Application
        4.1.2 Global Price by Application
    4.2 China
        4.2.1 China Sales by Application
        4.2.2 China Price by Application
5 China Trade
    5.1 Export
    5.2 Import
6 Key Manufacturers
    6.1 Novartis
        6.1.1 Company Information
        6.1.2 Product Specifications
        6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    6.2 Novo Nordisk
    6.3 Boehringer Ingelheim
    6.4 Bristol-Myers Squibb
    6.5 Eli Lilly
    6.6 MannKind
    6.7 Sanofi
    6.8 Merck
    6.9 Bioton
    6.10 GEA
    6.11 Emisphere
    6.12 Salix Pharmaceuticals
    6.13 Gan & Lee
    6.14 Dongbao
    6.15 United Laboratories (TUL)
    6.16 Takeda Pharmaceutical Company
    6.17 Shihuida PHARMA Group
    6.18 Henan Tian Fang Pharmaceutical
    6.19 Disha Pharmaceutical Group
7 Industry Upstream
    7.1 Industry Chain
    7.2 Raw Materials
8 Market Environment
    8.1 SWOT
    8.2 Porter's Five Forces
9 Conclusion
Figure Ultra-short-acting insulin Market Size and CAGR 2013-2018 (Million USD)
Figure Ultra-short-acting insulin Market Size and CAGR 2013-2018 (Volume)
Figure Ultra-short-acting insulin Market Forecast and CAGR 2019-2025 (Million USD)
Figure Ultra-short-acting insulin Market Forecast and CAGR 2019-2025 (Volume)
Figure Short-acting insulin Market Size and CAGR 2013-2018 (Million USD)
Figure Short-acting insulin Market Size and CAGR 2013-2018 (Volume)
Figure Short-acting insulin Market Forecast and CAGR 2019-2025 (Million USD)
Figure Short-acting insulin Market Forecast and CAGR 2019-2025 (Volume)
Figure In effect insulin Market Size and CAGR 2013-2018 (Million USD)
Figure In effect insulin Market Size and CAGR 2013-2018 (Volume)
Figure In effect insulin Market Forecast and CAGR 2019-2025 (Million USD)
Figure In effect insulin Market Forecast and CAGR 2019-2025 (Volume)
Figure Long-acting insulin Market Size and CAGR 2013-2018 (Million USD)
Figure Long-acting insulin Market Size and CAGR 2013-2018 (Volume)
Figure Long-acting insulin Market Forecast and CAGR 2019-2025 (Million USD)
Figure Long-acting insulin Market Forecast and CAGR 2019-2025 (Volume)
Figure Type 1 diabetes Market Size and CAGR 2013-2018 (Million USD)
Figure Type 1 diabetes Market Size and CAGR 2013-2018 (Volume)
Figure Type 1 diabetes Market Forecast and CAGR 2019-2025 (Million USD)
Figure Type 1 diabetes Market Forecast and CAGR 2019-2025 (Volume)
Figure Type 2 diabetes Market Size and CAGR 2013-2018 (Million USD)
Figure Type 2 diabetes Market Size and CAGR 2013-2018 (Volume)
Figure Type 2 diabetes Market Forecast and CAGR 2019-2025 (Million USD)
Figure Type 2 diabetes Market Forecast and CAGR 2019-2025 (Volume)
Figure Others diabetes Market Size and CAGR 2013-2018 (Million USD)
Figure Others diabetes Market Size and CAGR 2013-2018 (Volume)
Figure Others diabetes Market Forecast and CAGR 2019-2025 (Million USD)
Figure Others diabetes Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Insulin Market Size and CAGR 2013-2017 (Million USD)
Figure Global Insulin Market Size and CAGR 2013-2017 (Volume)
Figure Global Insulin Market Forecast and CAGR 2019-2025 (Million USD)
Figure Global Insulin Market Forecast and CAGR 2019-2025 (Volume)
Figure China Insulin Market Size and CAGR 2013-2017 (Million USD)
Figure China Insulin Market Size and CAGR 2013-2017 (Volume)
Figure China Insulin Market Forecast and CAGR 2019-2025 (Million USD)
Figure China Insulin Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Insulin SWOT List
Figure Insulin Porter's Five Forces